Clinical Trials in Detroit

Showing 12901-12920 of 19,719 trials

An Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary Cirrhosis

NCT02321306

Open-label, multicenter study in adults with Primary Biliary Cirrhosis (PBC) designed to evaluate the long-term safety and tolerability of daily dosing with LUM001.

Primary Biliary Cirrhosis

Mirum Pharmaceuticals, Inc.Started May 2015

La Jolla, California, United States • Sacramento, California, United States • Miami, Florida, United States +15 more locations

UNKNOWNPhase 2< 1 mile

Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis

NCT03205345

This is a multicenter, double-blind, randomized, placebo-controlled study to evaluate the safety and efficacy of emricasan in improving event-free survival based on a composite clinical endpoint (where all-cause mortality, new decompensation events, and MELD score progression are events) in subjects with decompensated NASH cirrhosis.

Decompensated Cirrhosis

Conatus Pharmaceuticals Inc.210 participantsStarted Jun 2017

Chandler, Arizona, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +73 more locations

An Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary Cirrhosis

Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis

Find Trials by Condition in Detroit

Study to Assess Duration of Indwelling Catheter After Sacrocolpopexy

Safety and Efficacy of Preoperative Antithrombin Supplementation in Patients Undergoing High-Risk Cardiopulmonary Bypass

Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine

ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab

A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer

Rate Control Versus Rhythm Control For Postoperative Atrial Fibrillation

DF4 Connector System Post-Approval Study

Phase IIIb Study of APD421 in Combination as PONV Prophylaxis

Comparing the Effectiveness of Repairing Versus Replacing the Heart's Mitral Valve in People With Severe Chronic Ischemic Mitral Regurgitation

Safety Study of ExAblate for the Treatment of Uterine Fibroids

A Dose Range Finding Study of JNJ-38518168 in Patients With Active Rheumatoid Arthritis in Spite of Treatment With Methotrexate

Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Nonvalvular Atrial Fibrillation (NVAF)

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

A Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Obese Children Aged 7 to 11 Years

Validation of the Itch Reported Outcome (ItchRO) Diaries in Pediatric Cholestatic Liver Disease

UltraShape Power for Abdominal Fat and Circumference Reduction

Post-eRADicAte - A Long Term Follow up of Subjects That Completed the eRADicAte Study (NCT 02097303)

52-104 Week Off-therapy Second Extension to Study CSPP100A2365